COVID-19 Yorkshire Rehabilitation Scale
An award-winning digital assessment and monitoring tool to help remotely manage individuals with persistent COVID symptoms. A not for profit initiative for all NHS organisations.
- Recommended by NHS England
- Funded by the NIHR
- Developed with NHS Trusts
- Used by the NHS across the UK
- Clinically validated for use in Long Covid
- Independently validated for assurance on clinical safety and information governance
- Contains other established outcome measures
For more information contact: c19-yrs@elaros.com
As Featured on BBC North West and ITV News Online
BBC North West recently featured the C19-YRS app on the 3rd September 2021 as part of an early implementation case study demonstrating its successful rollout at the Northern Care Alliance NHS Group.
The full news story can be read online on ITV News here.
The APP is user friendly and generally patients complete their YRS on the day we send the APP info out, resulting in their waiting time being reduced for their virtual appointment by at least 10-14 days.
The patient information is so easy to take from the C19 and add on to SystmOne and when we then require them to complete other measures it’s a super easy process to log back into the APP and amend which requirements we need next from them.
Postage and printing time and costs have been reduced massively, saving us several hours of work each week printing letters, posting out the YRS, asking patients to return it to us in an SAE and then having to scan the paper copy on to SystmOne. Any technical queries are answered and addressed in a very timely manner and the ELAROS team is so accessible and knowledgeable."
Cambridge and Peterborough
NHS Trust
Recommended by NHS England
NHS England has recommended routine use of C19-YRS at first assessment, 6 weeks and 6 months to monitor Long COVID in their National Guidance published in December 2020 and April 2021. The tool has also been recognised by NICE in their rapid guidelines for managing the long-term effects of COVID-19.
Created by clinical academics, supported by the NIHR
C19-YRS is a clinically validated outcome measure developed by clinical academics at The University of Leeds during the first wave of the pandemic. Its ongoing development and optimisation for delivery has been funded by the National Institute for Health Research.
Developed with NHS Trusts
Developed by clinicians across Leeds, Hull, and Airedale, with support from clinicians around the UK.
Supported by our first adopters in Salford Royal, Pennine Acute, and Liverpool University Hospitals NHS Trusts.
Enhanced by UK industry experts
Digitally enhanced by ELAROS 24/7 Ltd, building on their established CE-marked medical device, the Digital Bladder Diary platform. This project has been supported by Innovate UK.
Validation for clinical assurance
The digital C19-YRS has been independently validated by ORCHA as being compliant with national standards for usability, clinical safety, and information governance.
ELAROS has also met all standards for the NHS DSPT and obtained the CyberEssentials certification, demonstrating good practice in data security and protection.
NHS England has recommended routine use of C19-YRS at first assessment, 6 weeks and 6 months to monitor Long COVID in their National Guidance published in December 2020 and April 2021. The tool has also been recognised by NICE in their rapid guidelines for managing the long-term effects of COVID-19.
Award-winning system developed by an award-winning consortium
In September 2022, ELAROS and the Leeds Teaching Hospitals NHS Trust won a national award at the NHS Confederation and AHSN Network’s Innovate Awards in the ‘Outstanding Collaboration with Industry’ category for the development of the C19-YRS digital platform.
Leeds Community Healthcare and Leeds Teaching Hospitals NHS Trust won the 2021 BMJ Award for the ‘Clinical Leadership Team of the Year’ for the development of the UK’s first long COVID rehabilitation service and their follow on work in developing the digital C19-YRS platform with ELAROS.
ELAROS and The University of Leeds won Medipex’s 2021 Innovation Awards in its ‘Management of Long Term Conditions’ category for the development of the digital C19-YRS.
Benefits
For clinicians
- A suite of PROMs available to use
- Multiple patients managed in one place
- Helps capture symptoms and guide rehabilitation interventions for patients
- Digitally enhanced integrated care
- Clear clinical audit trail
- Supports reporting to NHS Improvement
- Powerful reporting and research tools
- Long term capture and analysis
- Access to updates from world-leading long COVID researchers
- Free lifetime updates to the app and portal
For patients
- Access to the validated C19-YRS designed for long Covid
- More reliable than a paper diary
- Automated data capture and assessment
- Completed anywhere, any time
- Digitally enhanced personalised care
- Completed alone or together with a carer or a HCP via telephone
- More informed rehabilitation interventions, potentially leading to better patient outcomes
- Sustainable remote patient monitoring
For research
- A research version of the platform is available to support projects using various PROMs
- Large scale remote data collection to drive research
- Supports clinics to conduct internal service evaluation
- Advanced vital research on post-COVID syndrome
- Development of a robust psychometric assessment of long COVID
Our Supporters
The digital C19-YRS has been developed by UK-based digital health company, ELAROS 24/7 Ltd, working closely with clinical researchers at The University of Leeds who developed the original self-report and provided initial funding to initiate the digital development with ELAROS’ third-party strategic partner software development company, Pipe & Piper in order to rapidly develop the platform to an industrial, clinically safe and secure standard. The scale was developed by clinicians at Leeds Teaching Hospitals Trust, Leeds Community Healthcare NHS Trust, and Airedale and Hull NHS Trusts.
It has been recommended for routine use by NHS England, funded by the NIHR, recognised by NICE, published in the ACNR, and endorsed by the British Society for Rehabilitation Medicine.
